Investegate announcements from Oncotelic Therapeutics, Oncotelic s Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022
AGOURA HILLS, CA, Dec. 14, 2021 Oncotelic Therapeutics, Inc. , a leading developer of TGF-β therapeutics for oncology and virology, today announced that the Company’s Chief Clinical. | December 14, 2021
DGAP-News: Oncotelic Therapeutics Oncotelic s Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022 14.12.2021 / 15:01 The issuer is solely responsible for the content of this announcement. Oncotelic Therapeutics, Inc. (Oncotelic or the C.